Wang14 found that overexpression of Notch2 in ESCC is closely related to overall survival (OS) and progression-free survival (PFS) and that its expression could serve as a biomarker to identify individuals with poor prognostic potential. This evidence concerns the gene NOTCH2 and esophageal squamous cell carcinoma.